Abe S et al. |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. |
2000 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10615065
|
Kiyota K et al. |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial. |
1999 |
J. Gastroenterol. |
pmid:10616771
|
Aoyama N et al. |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers. |
1999 |
J. Gastroenterol. |
pmid:10616772
|
Gotoda T et al. |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. |
1999 |
J. Gastroenterol. |
pmid:10616774
|
Maeda S et al. |
Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay. |
2000 |
J. Clin. Microbiol. |
pmid:10618089
|
Rocha RT et al. |
Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections. |
1999 |
Int. J. Clin. Pract. |
pmid:10622070
|
Lugannani C and Strickland C |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? |
1999 |
J Fam Pract |
pmid:10628582
|
Bui KQ et al. |
In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa. |
2000 |
J. Antimicrob. Chemother. |
pmid:10629013
|
Blondon H |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. |
1999 |
Presse Med |
pmid:10629694
|
Cammarota G et al. |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. |
1999 |
Dig. Dis. Sci. |
pmid:10630486
|
Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Hoshiya S et al. |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. |
2000 |
J. Gastroenterol. |
pmid:10632534
|
Fujioka T |
Clarithromycin resistance in Helicobacter pylori: implications for therapy. |
2000 |
J. Gastroenterol. |
pmid:10632546
|
Bardhan KD et al. |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632646
|
Vcev A et al. |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632647
|
Cammarota G et al. |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632648
|
Gasbarrini A et al. |
Efficacy of a multistep strategy for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632649
|
Chan FK et al. |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632651
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Keiser P et al. |
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. |
1999 |
Int J STD AIDS |
pmid:10639059
|
Miyanohara T et al. |
Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. |
2000 |
Laryngoscope |
pmid:10646728
|
Graham DY et al. |
Furazolidone combination therapies for Helicobacter pylori infection in the United States. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651662
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Fock KM et al. |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651664
|
Chiba N and Marshall CP |
Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. |
2000 |
Can. J. Gastroenterol. |
pmid:10655024
|
Alarcón T et al. |
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates. |
2000 |
J. Clin. Microbiol. |
pmid:10655418
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Yatsunami J et al. |
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. |
1999 |
Cancer Lett. |
pmid:10660084
|
Hoshi T et al. |
Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori--a comparison before and after H pylori eradication in non-atrophic gastritis. |
1999 |
Hum. Pathol. |
pmid:10667417
|
Mordi MN et al. |
Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. |
2000 |
J. Med. Chem. |
pmid:10669574
|
Griffith DE et al. |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. |
2000 |
Clin. Infect. Dis. |
pmid:10671330
|
Miyabayashi H et al. |
Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. |
2000 |
Helicobacter |
pmid:10672049
|
Dammann HG et al. |
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. |
2000 |
Helicobacter |
pmid:10672051
|
Calvet X et al. |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study. |
2000 |
Helicobacter |
pmid:10672052
|
Sevin E et al. |
[Helicobacter pylori: identification and detection of clarithromycin resistance by gene amplification]. |
2000 Jan-Feb |
Ann. Biol. Clin. (Paris) |
pmid:10673617
|
Kohri K et al. |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. |
2000 |
Eur. Respir. J. |
pmid:10678622
|
Jung R et al. |
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10681358
|
Suleymanlar I et al. |
Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients. |
1999 |
Adv Perit Dial |
pmid:10682076
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Gotfried MH |
Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance. |
2000 |
Clin Ther |
pmid:10688386
|
Bayerdörffer E |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol]. |
2000 |
Z Gastroenterol |
pmid:10689750
|
Szlachcic A et al. |
Helicobacter pylori and its eradication in rosacea. |
1999 |
J. Physiol. Pharmacol. |
pmid:10695558
|
Georgopoulos SD et al. |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. |
2000 |
Dig. Dis. Sci. |
pmid:10695615
|
Dore MP et al. |
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. |
2000 |
Dig. Dis. Sci. |
pmid:10695616
|
Miwa H et al. |
Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole. |
2000 |
Dig. Dis. Sci. |
pmid:10695617
|
Shamaly H et al. |
Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10697140
|
Ives TJ et al. |
In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected vero cell monolayers. |
2000 |
J. Antimicrob. Chemother. |
pmid:10702548
|
Schweeger I et al. |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. |
2000 |
Thromb. Res. |
pmid:10704650
|